Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination drug consisting of an antibiotic and dexamethasone (a corticosteroid). The specific antibiotics used in marketed products include tobramycin (Tobradex), ciprofloxacin (Ciprodex), or neomycin and polymyxin B (Maxitrol). These combinations are primarily used for the treatment of bacterial infections with associated inflammation—most commonly in the eye or ear. The antibiotic component acts by killing susceptible bacteria or inhibiting their growth; the dexamethasone component reduces inflammation by suppressing immune responses such as redness, swelling, and itching. This dual action helps both eradicate infection and control inflammatory symptoms[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on antibiotic + dexamethasone.